1 Publisher: Taylor & Francis Journal: Expert Opinion on Drug Delivery DOI: 10.1080/17425247.2016.1193150 REVIEW Could simvastatin be considered as a potential therapy for chronic lung diseases? A debate on the pros and cons Alaa S. Tulbah 1, 2 , Hui Xin Ong 1 , Paolo Colombo 3 , Paul M. Young 1 and Daniela Traini 1* 1 Respiratory Technology, Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical School, Sydney University, NSW, 2037, Australia 2 Faculty of Pharmacy, Umm Al Qura University, Makkah, Saudi Arabia 3 Department of Pharmacy, University of Parma, Parma, Italy *Corresponding author: Daniela Traini Respiratory Technology, Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical School, Sydney University, NSW, 2037, Australia E-mail: daniela.traini@sydney.edu.au